Alphabet’s Isomorphic Labs raises $600 million to advance AI drug design
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive
Isomorphic Labs, the AI drug discovery platform that was spun out of Google’s DeepMind in 2021, has raised external capital for the first time. The $600 million round was led by Thrive Capital, with ...
boursier.com16d
Cours Mini-Future : Alphabet Inc. C
La responsabilité de la société Investir Publications, éditrice du site Internet Boursier.com, ne saurait être engagée en cas d'erreur ou d'omission. Boursier.com recommande une ...
The Motley Fool27d
Prediction: Alphabet Stock Could Surge by 100% (or More) in the Next 5 Years
Alphabet is likely not as far behind in artificial intelligence as some assume. The company can probably afford to invest staggering sums to build and maintain its competitive edge. Still, amid ...